2023 ESC Guidelines for the management of endocarditis
- PMID: 37622656
- DOI: 10.1093/eurheartj/ehad193
2023 ESC Guidelines for the management of endocarditis
Erratum in
-
Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM).Eur Heart J. 2023 Dec 1;44(45):4780. doi: 10.1093/eurheartj/ehad625. Eur Heart J. 2023. PMID: 37738322 No abstract available.
-
Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM).Eur Heart J. 2024 Jan 1;45(1):56. doi: 10.1093/eurheartj/ehad776. Eur Heart J. 2024. PMID: 38086544 No abstract available.
-
Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM).Eur Heart J. 2025 Mar 13;46(11):1082. doi: 10.1093/eurheartj/ehae877. Eur Heart J. 2025. PMID: 39824219 No abstract available.
Keywords: Antibiotics; Cardiac imaging; Cardiac implantable electronic device; Cardiac surgery; Complications; Computed tomography; Congenital heart disease; Diagnosis; Echocardiography; Endocarditis; Guidelines; Infection; Nuclear imaging; Positron emission tomography; Prevention; Prognosis; Prosthetic heart valve; Valve disease.